Valuation: Mesa Laboratories, Inc.

Market Cap 63Cr 55Cr 51Cr 47Cr 88Cr 6.04TCr 89Cr 602.8Cr 235.78Cr 3.03TCr 237.82Cr 232.64Cr 10TCr P/E 2027 *
48.1x
P/E 2028 * 31.7x
Enterprise Value 63Cr 55Cr 51Cr 47Cr 88Cr 6.04TCr 89Cr 602.8Cr 235.78Cr 3.03TCr 237.82Cr 232.64Cr 10TCr EV / Sales 2027 *
2.48x
EV / Sales 2028 * 2.34x
Free-Float
94.59%
Yield 2027 *
0.6%
Yield 2028 * 0.6%
1 day-6.33%
1 week+4.98%
Current month+5.19%
1 month+11.68%
3 months+5.21%
6 months+17.05%
Current year+35.08%
1 week 93.03
Extreme 93.03
115.52
1 month 93.03
Extreme 93.03
115.52
Current year 71.06
Extreme 71.065
115.52
1 year 58.83
Extreme 58.8337
115.52
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 57 12/04/2026
Director of Finance/CFO 58 29/10/2012
Comptroller/Controller/Auditor 41 01/01/2022
Director TitleAgeSince
Chairman 73 01/09/2017
Director/Board Member 58 04/03/2019
Director/Board Member 57 11/05/2020
Date Insider Type Main position Quantity % Market Cap.
02/12/25 Don

Chairman

2,000 0.0362%
27/10/25 Fiscal year

Chief Executive Officer

11,558 0.2127%
18/08/25 Fiscal year

Director

7,708 0.1419%
Change 5-day change 1-year change 3-year change Capi.($)
-6.33%+4.98%+53.06%-24.05% 63Cr
-0.02%+3.05%-14.03%+5.64% 19TCr
+0.76%+6.23%-1.77%+9.37% 12TCr
+1.43%-3.44%+7.83%+67.49% 5.92TCr
+0.32%+4.59%+34.37%+62.62% 5.57TCr
+0.79%+3.57%-6.41%-35.04% 4.96TCr
-1.89%+8.11%+12.24%-19.64% 3.45TCr
+0.45%+3.56% - - 3.12TCr
+0.94%+0.24%+41.91%-11.48% 2.44TCr
+1.98%+15.59%-4.40%+22.62% 2.43TCr
Average -0.16%+4.89%+13.65%+8.61% 5.88TCr
Weighted average by Cap. +0.41%+3.54%+0.95%+13.46%

Financials

2027 *2028 *
Net sales 26Cr 22Cr 21Cr 19Cr 35Cr 2.44TCr 36Cr 242.95Cr 95Cr 1.22TCr 96Cr 94Cr 4.07TCr 27Cr 23Cr 22Cr 20Cr 37Cr 2.58TCr 38Cr 257.19Cr 100.6Cr 1.29TCr 101.47Cr 99Cr 4.31TCr
Net income 1.3Cr 1.13Cr 1.06Cr 96.45L 1.81Cr 124.52Cr 1.84Cr 12Cr 4.86Cr 62Cr 4.9Cr 4.79Cr 207.89Cr 2.11Cr 1.83Cr 1.72Cr 1.56Cr 2.93Cr 201.64Cr 2.98Cr 20Cr 7.87Cr 101.15Cr 7.93Cr 7.76Cr 336.66Cr
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
14/26/14 $106.04 -6.33% 1,61,032
13/26/13 $113.20 +0.35% 2,54,285
12/26/12 $112.80 +1.41% 1,94,137
11/26/11 $111.23 +9.46% 4,10,306
10/26/10 $101.62 -1.00% 1,03,051
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
106.04USD
Average target price
117.50USD
Spread / Average Target
+10.81%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock